Position in MRNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,546,703
+$3,285,157 QoQ
Shares Held
69,817
+687.2% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC WORLD MARKET INC. holds $46,729,574 across 25 Biotechnology names. MRNA ranks #3 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
488,266 | $13,100,176 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,078 | $12,537,950 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
69,817 | $3,546,703 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,766 | $2,909,762 | |
| 5 | RPRX |
Royalty Pharma plc
|
47,426 | $2,275,025 | |
| 6 | EXEL |
Exelixis, Inc.
|
38,204 | $1,638,569 | |
| 7 | ASND |
Ascendis Pharma A/S
|
6,381 | $1,459,526 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
69,215 | $1,254,867 |
All Filings in MRNA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,546,703 | 69,817 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $261,546 | 8,869 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $667,240 | 25,832 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $693,391 | 25,132 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,077,385 | 38,003 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,223,033 | 53,464 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,941,833 | 58,983 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,598,493 | 13,461 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $6,726,706 | 63,126 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,823,584 | 28,392 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,582,361 | 63,727 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,975,702 | 90,335 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $18,283,391 | 119,048 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $19,133,302 | 106,521 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,387,595 | 121,671 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $21,443,070 | 150,109 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $26,253,974 | 152,409 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $34,885,168 | 137,354 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $61,474,842 | 159,733 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,593,936 | 117,431 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $15,396,839 | 117,578 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,005,824 | 19,200 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $381,271 | 5,389 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,925,657 | 29,990 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||